Literature DB >> 6381532

Problems in determining immune status in borderline specimens in an enzyme immunoassay for rubella immunoglobulin G antibody.

R S Steece, M S Talley, M R Skeels, G A Lanier.   

Abstract

A total of 374 sera, found by enzyme-linked immunosorbent assay (Rubazyme; Abbott Laboratories, North Chicago, Ill.) to have borderline rubella antibody levels, were tested by hemagglutination inhibition. All sera had Rubazyme indexes in the range of 0.500 to 1.499. Rubazyme sensitivity was 59.0%, and specificity was 80.8%. The predictive value of Rubazyme-positive result was 91.4%, and that for a negative result was 36.4%. Immune and nonimmune results were significantly different between the two methods (P less than 0.001). The same sera were retested with the Rubazyme test, with an inter-run agreement of 75.3%. A significant difference in Rubazyme indexes between runs (P less than 0.001) was observed. An alternative method of testing specimens in the range close to the Rubazyme index cutoff value of 1.000 may be indicated.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6381532      PMCID: PMC271215          DOI: 10.1128/jcm.19.6.923-925.1984

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  3 in total

1.  Comparison of an enzyme-linked immunosorbent assay with indirect hemagglutination and hemagglutination inhibition for determination of rubella virus antibody: evaluation of immune status with commercial reagents in a clinical laboratory.

Authors:  A L Truant; B L Barksdale; T W Huber; L B Elliott
Journal:  J Clin Microbiol       Date:  1983-01       Impact factor: 5.948

2.  Comparison of hemagglutination inhibition test and enzyme-linked immunosorbent assay for determining antibody to rubella virus.

Authors:  I C Shekarchi; J L Sever; N Tzan; A Ley; L C Ward; D Madden
Journal:  J Clin Microbiol       Date:  1981-05       Impact factor: 5.948

3.  Rubella antibodies detected by several commercial immunoassays in hemagglutination inhibition-negative sera.

Authors:  K T Kleeman; D J Kiefer; S P Halbert
Journal:  J Clin Microbiol       Date:  1983-11       Impact factor: 5.948

  3 in total
  5 in total

1.  Multicenter evaluation of five commercial rubella virus immunoglobulin G kits which report in international units per milliliter.

Authors:  W Dimech; A Bettoli; D Eckert; B Francis; J Hamblin; T Kerr; C Ryan; I Skurrie
Journal:  J Clin Microbiol       Date:  1992-03       Impact factor: 5.948

2.  Evaluation of eight anti-rubella virus immunoglobulin g immunoassays that report results in international units per milliliter.

Authors:  Wayne Dimech; Lena Panagiotopoulos; Barbara Francis; Nicholas Laven; Joan Marler; David Dickeson; Tony Panayotou; Kim Wilson; Robyn Wootten; Elizabeth M Dax
Journal:  J Clin Microbiol       Date:  2008-04-23       Impact factor: 5.948

3.  Differences in antibody responses with rapid agglutination tests for the detection of rubella antibodies.

Authors:  M A Chernesky; D J DeLong; J B Mahony; S Castriciano
Journal:  J Clin Microbiol       Date:  1986-04       Impact factor: 5.948

4.  Comparison of enzyme-linked immunosorbent assay, hemagglutination inhibition, and passive latex agglutination for determination of rubella immune status.

Authors:  R S Steece; M S Talley; M R Skeels; G A Lanier
Journal:  J Clin Microbiol       Date:  1985-01       Impact factor: 5.948

5.  Determination of immune status in patients with low antibody titers for rubella virus.

Authors:  S L Fayram; S Akin; S L Aarnaes; E M Peterson; L M de la Maza
Journal:  J Clin Microbiol       Date:  1987-01       Impact factor: 5.948

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.